Search Results

Adherence, tolerability are key in treatment of hypertension, glaucoma: Priorities can ensure optimal outcomes for patients diagnosed with diseases.

• Authors : Larsen, Christine; Ristvedt, Deborah

Subjects: GLAUCOMA surgery; CUTANEOUS therapeutics; PATIENT compliance

• Source: Ophthalmology Times. Apr2024, Vol. 49 Issue 4, p16-18. 2p.

Record details

Bimatoprost implant reduces IOP for 2 years or more.

• Authors : Charters, Lynda

Subjects: BIMATOPROST; DRUG approval; GLAUCOMA

• Source: Ophthalmology Times. Jan2022, Vol. 47 Issue 1, p14-15. 2p.

Record details

Strategic combinations: How to pair energy-based devices with injectables.

• Authors : PALMER, WHITNEY J.

Subjects: BOTULINUM toxin; THERAPEUTICS; MEDICAL technology equipment

• Source: Dermatology Times. May2018, Vol. 39 Issue 5, p1-58. 3p.

Record details

Bimatoprost implant: Taking a holiday from glaucoma drops.

• Authors : Charters, Lynda; Bunin, Lisa

Subjects: BIMATOPROST; GLAUCOMA; CONTROLLED release drugs

• Source: Ophthalmology Times. Aug2022, Vol. 47 Issue 8, p24-24. 1p.

Record details

CONTINUING MEDICAL EDUCATION. 3 Things You Should Know About Glaucoma.

• Authors : Smith, Oluwatosin U.

Subjects: BIMATOPROST; GLAUCOMA; INTRAOCULAR pressure

• Source: Ophthalmology Times. May2021, Vol. 46 Issue 8, p32-33. 2p.

Record details

Bimatoprost SR may offer long-term lowering of IOP: Study zeroes in on the sustained mechanism of action of the therapeutic.

• Authors : Charters, Lynda; Rhee, Douglas J.

Subjects: BIMATOPROST; INTRAOCULAR pressure; MATRIX metalloproteinasesOHIO

• Source: Ophthalmology Times. May2022, Vol. 47 Issue 5, p20-20. 1p.

Record details

Selecting Adjunctive Therapy.

Subjects: COLLEGE teachers; DRUGS; GLAUCOMA

• Source: Ophthalmology Times. 8/1/2013 Supplement, p3-12. 10p.

Record details

Ophthalmology Briefing: Expert Guidance on IOP Targets and Ocular Health in Glaucoma.

Subjects: GLAUCOMA treatment; DRUG therapy; CONTROLLED release drugs

• Source: Ophthalmology Times. 3/15/2020, Vol. 45 Issue 5, p26-27. 2p.

Record details

Sustained-release implant offers long-term IOP control, preserved visual function: Bimatoprost SR represents a paradigm shift in glaucoma treatment.

• Authors : Charters, Lynda

Subjects: CLINICAL trials; CONTROLLED release preparations; CONTROLLED release drugs

• Source: Ophthalmology Times. 3/15/2020, Vol. 45 Issue 5, p1-16. 2p.

Record details

Pharmacologic pipeline makes waves in glaucoma.

• Authors : Gebhart, Fred; Lindstrom, Richard L.

Subjects: INTRANASAL medication; ANTI-infective agents; COMBINATION drug therapy

• Source: Ophthalmology Times. 4/15/2019, Vol. 44 Issue 7, p30-30. 1p.

Record details